Recent Company News

• 11:40 PM ET Aug 19, 2026
  

  Street Takeaways - Cochlear FY Earnings (A$138.56, +1.26)

• 07:22 PM ET Aug 18, 2026
  

  Cochlear upgraded to neutral from sell at Citi (A$141.20, 0.00)

• 02:25 PM ET Aug 18, 2026
  

  Cochlear downgraded to hold from buy at Canaccord Genuity (A$141.20, 0.00)

• 11:41 PM ET Aug 17, 2026
  

  Transcript Intelligence: Cochlear Q4 Earnings Guidance

• 11:41 PM ET Aug 17, 2026
  

  Transcript Intelligence: Cochlear Q4 Earnings Themes

• 11:41 PM ET Aug 17, 2026
  

  Transcript Intelligence: Cochlear Q4 Earnings Q&A

• 09:52 PM ET Aug 17, 2026
  

  Quick Take: Cochlear +7% on profit beat driven by costs; implant unit growth strong; pricing soft on China mix (A$140.63, +9.38)

• 09:40 PM ET Aug 17, 2026
  

  StreetAccount Summary - Trading higher/lower: Australia & New Zealand midday

• 05:46 PM ET Aug 17, 2026
  

  StreetAccount Metrics Recap - Cochlear FY Earnings (A$131.25, 0.00)

• 05:40 PM ET Aug 17, 2026
  

  Cochlear reports FY underlying NPAT A$322.4M vs StreetAccount A$298.8M (A$131.25, 0.00)